McLaren Health Care
Research Policies and Procedures

IRB Policies & Procedures

This section includes policies and procedures that aid investigators, researchers, Institutional Review Board members, and others involved in human subject research in fulfilling their obligation to ensure that research is conducted and approved consistently and in compliance with applicable laws, regulations and MHC’s commitment to the protection of its research participants.

Persons conducting, supporting or reviewing research throughout MHC and its subsidiary hospitals should familiarize themselves with these policies and procedures. This section should be referenced regularly as policies, procedures and guidelines are revised to stay current with evolving issues and regulations related to human research.

If you wish to provide comments or suggestions on MHC HRPP policy and procedures, organization of materials on this website, or other human subject protection issues, please email the HRPP office at hrpp@mclaren.org.

Thank you for your cooperation!

AAHRPP seal

Human Subject Research During COVID-19 Pandemic

Interim MHC Policy on Human Subject Research During COVID-19 Pandemic

Revised Common Rule

Common Rule
MHC_RP0500 Transition and IRB Review of Research Subject to the Revised 2018 Common Rule

Policies and Procedures

We are currently updating the information for this page. Please check back soon, or contact us with any questions at (248) 484-4950 or hrpp@mclaren.org.

Pre-2018 Common Rule Policies

MHC_RP0105 Exempt Review of Human Subject Research (pre 2018 Common Rule)
MHC_RP0106 Expedited Review of Human Subject Research (pre 2018 Common Rule)
MHC_RP0115 Obtaining Informed Consent from Research Subjects (pre 2018 Common Rule)
Example Waiver of Informed Consent (pre 2018 Common Rule)
Example Waiver of Documentation of Informed Consent (pre 2018 Common Rule)
Translation Requirements Guidance (pre 2018 Common Rule)